Clinical trial
Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence
NCT00463775 is registered in ClinicalTrials.gov with Elizabeth Ralevski as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence
- Lead sponsor
- Elizabeth Ralevski
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- March 31, 2007
- Completion date
- May 31, 2009
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol dependence, borderline personality disorder